Global Primary Hyperoxaluria Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Primary Hyperoxaluria Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Primary Hyperoxaluria Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Primary Hyperoxaluria Drug market. Primary Hyperoxaluria Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Primary Hyperoxaluria Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Primary Hyperoxaluria Drug market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Primary Hyperoxaluria Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Primary Hyperoxaluria Drug market. It may include historical data, market segmentation by Type (e.g., ALLN-230, DCR-PHXC), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Primary Hyperoxaluria Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Primary Hyperoxaluria Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Primary Hyperoxaluria Drug industry. This include advancements in Primary Hyperoxaluria Drug technology, Primary Hyperoxaluria Drug new entrants, Primary Hyperoxaluria Drug new investment, and other innovations that are shaping the future of Primary Hyperoxaluria Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Primary Hyperoxaluria Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Primary Hyperoxaluria Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Primary Hyperoxaluria Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Primary Hyperoxaluria Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Primary Hyperoxaluria Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Primary Hyperoxaluria Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Primary Hyperoxaluria Drug market.
Market Segmentation:
Primary Hyperoxaluria Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Primary Hyperoxaluria Drug market?
What factors are driving Primary Hyperoxaluria Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Primary Hyperoxaluria Drug market opportunities vary by end market size?
How does Primary Hyperoxaluria Drug break out type, application?
According to our LPI (LP Information) latest study, the global Primary Hyperoxaluria Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Primary Hyperoxaluria Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Primary Hyperoxaluria Drug market. Primary Hyperoxaluria Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Primary Hyperoxaluria Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Primary Hyperoxaluria Drug market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Primary Hyperoxaluria Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Primary Hyperoxaluria Drug market. It may include historical data, market segmentation by Type (e.g., ALLN-230, DCR-PHXC), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Primary Hyperoxaluria Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Primary Hyperoxaluria Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Primary Hyperoxaluria Drug industry. This include advancements in Primary Hyperoxaluria Drug technology, Primary Hyperoxaluria Drug new entrants, Primary Hyperoxaluria Drug new investment, and other innovations that are shaping the future of Primary Hyperoxaluria Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Primary Hyperoxaluria Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Primary Hyperoxaluria Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Primary Hyperoxaluria Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Primary Hyperoxaluria Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Primary Hyperoxaluria Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Primary Hyperoxaluria Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Primary Hyperoxaluria Drug market.
Market Segmentation:
Primary Hyperoxaluria Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- ALLN-230
- DCR-PHXC
- ALN-GO1
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Allena Pharmaceuticals Inc
- Alnylam Pharmaceuticals Inc
- Dicerna Pharmaceuticals Inc
- Intellia Therapeutics Inc
- OxThera AB
What is the 10-year outlook for the global Primary Hyperoxaluria Drug market?
What factors are driving Primary Hyperoxaluria Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Primary Hyperoxaluria Drug market opportunities vary by end market size?
How does Primary Hyperoxaluria Drug break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Primary Hyperoxaluria Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Primary Hyperoxaluria Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Primary Hyperoxaluria Drug by Country/Region, 2019, 2023 & 2030
2.2 Primary Hyperoxaluria Drug Segment by Type
2.2.1 ALLN-230
2.2.2 DCR-PHXC
2.2.3 ALN-GO1
2.2.4 Others
2.3 Primary Hyperoxaluria Drug Sales by Type
2.3.1 Global Primary Hyperoxaluria Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Primary Hyperoxaluria Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Primary Hyperoxaluria Drug Sale Price by Type (2019-2024)
2.4 Primary Hyperoxaluria Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Primary Hyperoxaluria Drug Sales by Application
2.5.1 Global Primary Hyperoxaluria Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Primary Hyperoxaluria Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Primary Hyperoxaluria Drug Sale Price by Application (2019-2024)
3 GLOBAL PRIMARY HYPEROXALURIA DRUG BY COMPANY
3.1 Global Primary Hyperoxaluria Drug Breakdown Data by Company
3.1.1 Global Primary Hyperoxaluria Drug Annual Sales by Company (2019-2024)
3.1.2 Global Primary Hyperoxaluria Drug Sales Market Share by Company (2019-2024)
3.2 Global Primary Hyperoxaluria Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Primary Hyperoxaluria Drug Revenue by Company (2019-2024)
3.2.2 Global Primary Hyperoxaluria Drug Revenue Market Share by Company (2019-2024)
3.3 Global Primary Hyperoxaluria Drug Sale Price by Company
3.4 Key Manufacturers Primary Hyperoxaluria Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Primary Hyperoxaluria Drug Product Location Distribution
3.4.2 Players Primary Hyperoxaluria Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PRIMARY HYPEROXALURIA DRUG BY GEOGRAPHIC REGION
4.1 World Historic Primary Hyperoxaluria Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Primary Hyperoxaluria Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Primary Hyperoxaluria Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Primary Hyperoxaluria Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Primary Hyperoxaluria Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Primary Hyperoxaluria Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Primary Hyperoxaluria Drug Sales Growth
4.4 APAC Primary Hyperoxaluria Drug Sales Growth
4.5 Europe Primary Hyperoxaluria Drug Sales Growth
4.6 Middle East & Africa Primary Hyperoxaluria Drug Sales Growth
5 AMERICAS
5.1 Americas Primary Hyperoxaluria Drug Sales by Country
5.1.1 Americas Primary Hyperoxaluria Drug Sales by Country (2019-2024)
5.1.2 Americas Primary Hyperoxaluria Drug Revenue by Country (2019-2024)
5.2 Americas Primary Hyperoxaluria Drug Sales by Type
5.3 Americas Primary Hyperoxaluria Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Primary Hyperoxaluria Drug Sales by Region
6.1.1 APAC Primary Hyperoxaluria Drug Sales by Region (2019-2024)
6.1.2 APAC Primary Hyperoxaluria Drug Revenue by Region (2019-2024)
6.2 APAC Primary Hyperoxaluria Drug Sales by Type
6.3 APAC Primary Hyperoxaluria Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Primary Hyperoxaluria Drug by Country
7.1.1 Europe Primary Hyperoxaluria Drug Sales by Country (2019-2024)
7.1.2 Europe Primary Hyperoxaluria Drug Revenue by Country (2019-2024)
7.2 Europe Primary Hyperoxaluria Drug Sales by Type
7.3 Europe Primary Hyperoxaluria Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Primary Hyperoxaluria Drug by Country
8.1.1 Middle East & Africa Primary Hyperoxaluria Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Primary Hyperoxaluria Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Primary Hyperoxaluria Drug Sales by Type
8.3 Middle East & Africa Primary Hyperoxaluria Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Primary Hyperoxaluria Drug
10.3 Manufacturing Process Analysis of Primary Hyperoxaluria Drug
10.4 Industry Chain Structure of Primary Hyperoxaluria Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Primary Hyperoxaluria Drug Distributors
11.3 Primary Hyperoxaluria Drug Customer
12 WORLD FORECAST REVIEW FOR PRIMARY HYPEROXALURIA DRUG BY GEOGRAPHIC REGION
12.1 Global Primary Hyperoxaluria Drug Market Size Forecast by Region
12.1.1 Global Primary Hyperoxaluria Drug Forecast by Region (2025-2030)
12.1.2 Global Primary Hyperoxaluria Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Primary Hyperoxaluria Drug Forecast by Type
12.7 Global Primary Hyperoxaluria Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Allena Pharmaceuticals Inc
13.1.1 Allena Pharmaceuticals Inc Company Information
13.1.2 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
13.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Allena Pharmaceuticals Inc Main Business Overview
13.1.5 Allena Pharmaceuticals Inc Latest Developments
13.2 Alnylam Pharmaceuticals Inc
13.2.1 Alnylam Pharmaceuticals Inc Company Information
13.2.2 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
13.2.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Alnylam Pharmaceuticals Inc Main Business Overview
13.2.5 Alnylam Pharmaceuticals Inc Latest Developments
13.3 Dicerna Pharmaceuticals Inc
13.3.1 Dicerna Pharmaceuticals Inc Company Information
13.3.2 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
13.3.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Dicerna Pharmaceuticals Inc Main Business Overview
13.3.5 Dicerna Pharmaceuticals Inc Latest Developments
13.4 Intellia Therapeutics Inc
13.4.1 Intellia Therapeutics Inc Company Information
13.4.2 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
13.4.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Intellia Therapeutics Inc Main Business Overview
13.4.5 Intellia Therapeutics Inc Latest Developments
13.5 OxThera AB
13.5.1 OxThera AB Company Information
13.5.2 OxThera AB Primary Hyperoxaluria Drug Product Portfolios and Specifications
13.5.3 OxThera AB Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 OxThera AB Main Business Overview
13.5.5 OxThera AB Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Primary Hyperoxaluria Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Primary Hyperoxaluria Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Primary Hyperoxaluria Drug by Country/Region, 2019, 2023 & 2030
2.2 Primary Hyperoxaluria Drug Segment by Type
2.2.1 ALLN-230
2.2.2 DCR-PHXC
2.2.3 ALN-GO1
2.2.4 Others
2.3 Primary Hyperoxaluria Drug Sales by Type
2.3.1 Global Primary Hyperoxaluria Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Primary Hyperoxaluria Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Primary Hyperoxaluria Drug Sale Price by Type (2019-2024)
2.4 Primary Hyperoxaluria Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Primary Hyperoxaluria Drug Sales by Application
2.5.1 Global Primary Hyperoxaluria Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Primary Hyperoxaluria Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Primary Hyperoxaluria Drug Sale Price by Application (2019-2024)
3 GLOBAL PRIMARY HYPEROXALURIA DRUG BY COMPANY
3.1 Global Primary Hyperoxaluria Drug Breakdown Data by Company
3.1.1 Global Primary Hyperoxaluria Drug Annual Sales by Company (2019-2024)
3.1.2 Global Primary Hyperoxaluria Drug Sales Market Share by Company (2019-2024)
3.2 Global Primary Hyperoxaluria Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Primary Hyperoxaluria Drug Revenue by Company (2019-2024)
3.2.2 Global Primary Hyperoxaluria Drug Revenue Market Share by Company (2019-2024)
3.3 Global Primary Hyperoxaluria Drug Sale Price by Company
3.4 Key Manufacturers Primary Hyperoxaluria Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Primary Hyperoxaluria Drug Product Location Distribution
3.4.2 Players Primary Hyperoxaluria Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PRIMARY HYPEROXALURIA DRUG BY GEOGRAPHIC REGION
4.1 World Historic Primary Hyperoxaluria Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Primary Hyperoxaluria Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Primary Hyperoxaluria Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Primary Hyperoxaluria Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Primary Hyperoxaluria Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Primary Hyperoxaluria Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Primary Hyperoxaluria Drug Sales Growth
4.4 APAC Primary Hyperoxaluria Drug Sales Growth
4.5 Europe Primary Hyperoxaluria Drug Sales Growth
4.6 Middle East & Africa Primary Hyperoxaluria Drug Sales Growth
5 AMERICAS
5.1 Americas Primary Hyperoxaluria Drug Sales by Country
5.1.1 Americas Primary Hyperoxaluria Drug Sales by Country (2019-2024)
5.1.2 Americas Primary Hyperoxaluria Drug Revenue by Country (2019-2024)
5.2 Americas Primary Hyperoxaluria Drug Sales by Type
5.3 Americas Primary Hyperoxaluria Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Primary Hyperoxaluria Drug Sales by Region
6.1.1 APAC Primary Hyperoxaluria Drug Sales by Region (2019-2024)
6.1.2 APAC Primary Hyperoxaluria Drug Revenue by Region (2019-2024)
6.2 APAC Primary Hyperoxaluria Drug Sales by Type
6.3 APAC Primary Hyperoxaluria Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Primary Hyperoxaluria Drug by Country
7.1.1 Europe Primary Hyperoxaluria Drug Sales by Country (2019-2024)
7.1.2 Europe Primary Hyperoxaluria Drug Revenue by Country (2019-2024)
7.2 Europe Primary Hyperoxaluria Drug Sales by Type
7.3 Europe Primary Hyperoxaluria Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Primary Hyperoxaluria Drug by Country
8.1.1 Middle East & Africa Primary Hyperoxaluria Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Primary Hyperoxaluria Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Primary Hyperoxaluria Drug Sales by Type
8.3 Middle East & Africa Primary Hyperoxaluria Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Primary Hyperoxaluria Drug
10.3 Manufacturing Process Analysis of Primary Hyperoxaluria Drug
10.4 Industry Chain Structure of Primary Hyperoxaluria Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Primary Hyperoxaluria Drug Distributors
11.3 Primary Hyperoxaluria Drug Customer
12 WORLD FORECAST REVIEW FOR PRIMARY HYPEROXALURIA DRUG BY GEOGRAPHIC REGION
12.1 Global Primary Hyperoxaluria Drug Market Size Forecast by Region
12.1.1 Global Primary Hyperoxaluria Drug Forecast by Region (2025-2030)
12.1.2 Global Primary Hyperoxaluria Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Primary Hyperoxaluria Drug Forecast by Type
12.7 Global Primary Hyperoxaluria Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Allena Pharmaceuticals Inc
13.1.1 Allena Pharmaceuticals Inc Company Information
13.1.2 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
13.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Allena Pharmaceuticals Inc Main Business Overview
13.1.5 Allena Pharmaceuticals Inc Latest Developments
13.2 Alnylam Pharmaceuticals Inc
13.2.1 Alnylam Pharmaceuticals Inc Company Information
13.2.2 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
13.2.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Alnylam Pharmaceuticals Inc Main Business Overview
13.2.5 Alnylam Pharmaceuticals Inc Latest Developments
13.3 Dicerna Pharmaceuticals Inc
13.3.1 Dicerna Pharmaceuticals Inc Company Information
13.3.2 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
13.3.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Dicerna Pharmaceuticals Inc Main Business Overview
13.3.5 Dicerna Pharmaceuticals Inc Latest Developments
13.4 Intellia Therapeutics Inc
13.4.1 Intellia Therapeutics Inc Company Information
13.4.2 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
13.4.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Intellia Therapeutics Inc Main Business Overview
13.4.5 Intellia Therapeutics Inc Latest Developments
13.5 OxThera AB
13.5.1 OxThera AB Company Information
13.5.2 OxThera AB Primary Hyperoxaluria Drug Product Portfolios and Specifications
13.5.3 OxThera AB Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 OxThera AB Main Business Overview
13.5.5 OxThera AB Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Primary Hyperoxaluria Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Primary Hyperoxaluria Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of ALLN-230
Table 4. Major Players of DCR-PHXC
Table 5. Major Players of ALN-GO1
Table 6. Major Players of Others
Table 7. Global Primary Hyperoxaluria Drug Sales by Type (2019-2024) & (K Pcs)
Table 8. Global Primary Hyperoxaluria Drug Sales Market Share by Type (2019-2024)
Table 9. Global Primary Hyperoxaluria Drug Revenue by Type (2019-2024) & ($ million)
Table 10. Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2019-2024)
Table 11. Global Primary Hyperoxaluria Drug Sale Price by Type (2019-2024) & (USD/Pcs)
Table 12. Global Primary Hyperoxaluria Drug Sales by Application (2019-2024) & (K Pcs)
Table 13. Global Primary Hyperoxaluria Drug Sales Market Share by Application (2019-2024)
Table 14. Global Primary Hyperoxaluria Drug Revenue by Application (2019-2024)
Table 15. Global Primary Hyperoxaluria Drug Revenue Market Share by Application (2019-2024)
Table 16. Global Primary Hyperoxaluria Drug Sale Price by Application (2019-2024) & (USD/Pcs)
Table 17. Global Primary Hyperoxaluria Drug Sales by Company (2019-2024) & (K Pcs)
Table 18. Global Primary Hyperoxaluria Drug Sales Market Share by Company (2019-2024)
Table 19. Global Primary Hyperoxaluria Drug Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Primary Hyperoxaluria Drug Revenue Market Share by Company (2019-2024)
Table 21. Global Primary Hyperoxaluria Drug Sale Price by Company (2019-2024) & (USD/Pcs)
Table 22. Key Manufacturers Primary Hyperoxaluria Drug Producing Area Distribution and Sales Area
Table 23. Players Primary Hyperoxaluria Drug Products Offered
Table 24. Primary Hyperoxaluria Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Primary Hyperoxaluria Drug Sales by Geographic Region (2019-2024) & (K Pcs)
Table 28. Global Primary Hyperoxaluria Drug Sales Market Share Geographic Region (2019-2024)
Table 29. Global Primary Hyperoxaluria Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Primary Hyperoxaluria Drug Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Primary Hyperoxaluria Drug Sales by Country/Region (2019-2024) & (K Pcs)
Table 32. Global Primary Hyperoxaluria Drug Sales Market Share by Country/Region (2019-2024)
Table 33. Global Primary Hyperoxaluria Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Primary Hyperoxaluria Drug Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Primary Hyperoxaluria Drug Sales by Country (2019-2024) & (K Pcs)
Table 36. Americas Primary Hyperoxaluria Drug Sales Market Share by Country (2019-2024)
Table 37. Americas Primary Hyperoxaluria Drug Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Primary Hyperoxaluria Drug Revenue Market Share by Country (2019-2024)
Table 39. Americas Primary Hyperoxaluria Drug Sales by Type (2019-2024) & (K Pcs)
Table 40. Americas Primary Hyperoxaluria Drug Sales by Application (2019-2024) & (K Pcs)
Table 41. APAC Primary Hyperoxaluria Drug Sales by Region (2019-2024) & (K Pcs)
Table 42. APAC Primary Hyperoxaluria Drug Sales Market Share by Region (2019-2024)
Table 43. APAC Primary Hyperoxaluria Drug Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Primary Hyperoxaluria Drug Revenue Market Share by Region (2019-2024)
Table 45. APAC Primary Hyperoxaluria Drug Sales by Type (2019-2024) & (K Pcs)
Table 46. APAC Primary Hyperoxaluria Drug Sales by Application (2019-2024) & (K Pcs)
Table 47. Europe Primary Hyperoxaluria Drug Sales by Country (2019-2024) & (K Pcs)
Table 48. Europe Primary Hyperoxaluria Drug Sales Market Share by Country (2019-2024)
Table 49. Europe Primary Hyperoxaluria Drug Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Primary Hyperoxaluria Drug Revenue Market Share by Country (2019-2024)
Table 51. Europe Primary Hyperoxaluria Drug Sales by Type (2019-2024) & (K Pcs)
Table 52. Europe Primary Hyperoxaluria Drug Sales by Application (2019-2024) & (K Pcs)
Table 53. Middle East & Africa Primary Hyperoxaluria Drug Sales by Country (2019-2024) & (K Pcs)
Table 54. Middle East & Africa Primary Hyperoxaluria Drug Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Primary Hyperoxaluria Drug Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Primary Hyperoxaluria Drug Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Primary Hyperoxaluria Drug Sales by Type (2019-2024) & (K Pcs)
Table 58. Middle East & Africa Primary Hyperoxaluria Drug Sales by Application (2019-2024) & (K Pcs)
Table 59. Key Market Drivers & Growth Opportunities of Primary Hyperoxaluria Drug
Table 60. Key Market Challenges & Risks of Primary Hyperoxaluria Drug
Table 61. Key Industry Trends of Primary Hyperoxaluria Drug
Table 62. Primary Hyperoxaluria Drug Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Primary Hyperoxaluria Drug Distributors List
Table 65. Primary Hyperoxaluria Drug Customer List
Table 66. Global Primary Hyperoxaluria Drug Sales Forecast by Region (2025-2030) & (K Pcs)
Table 67. Global Primary Hyperoxaluria Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Primary Hyperoxaluria Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 69. Americas Primary Hyperoxaluria Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Primary Hyperoxaluria Drug Sales Forecast by Region (2025-2030) & (K Pcs)
Table 71. APAC Primary Hyperoxaluria Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Primary Hyperoxaluria Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 73. Europe Primary Hyperoxaluria Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Primary Hyperoxaluria Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 75. Middle East & Africa Primary Hyperoxaluria Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Primary Hyperoxaluria Drug Sales Forecast by Type (2025-2030) & (K Pcs)
Table 77. Global Primary Hyperoxaluria Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Primary Hyperoxaluria Drug Sales Forecast by Application (2025-2030) & (K Pcs)
Table 79. Global Primary Hyperoxaluria Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Allena Pharmaceuticals Inc Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
Table 82. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Allena Pharmaceuticals Inc Main Business
Table 84. Allena Pharmaceuticals Inc Latest Developments
Table 85. Alnylam Pharmaceuticals Inc Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
Table 87. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Alnylam Pharmaceuticals Inc Main Business
Table 89. Alnylam Pharmaceuticals Inc Latest Developments
Table 90. Dicerna Pharmaceuticals Inc Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
Table 92. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. Dicerna Pharmaceuticals Inc Main Business
Table 94. Dicerna Pharmaceuticals Inc Latest Developments
Table 95. Intellia Therapeutics Inc Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
Table 97. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Intellia Therapeutics Inc Main Business
Table 99. Intellia Therapeutics Inc Latest Developments
Table 100. OxThera AB Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. OxThera AB Primary Hyperoxaluria Drug Product Portfolios and Specifications
Table 102. OxThera AB Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. OxThera AB Main Business
Table 104. OxThera AB Latest Developments
Table 1. Primary Hyperoxaluria Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Primary Hyperoxaluria Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of ALLN-230
Table 4. Major Players of DCR-PHXC
Table 5. Major Players of ALN-GO1
Table 6. Major Players of Others
Table 7. Global Primary Hyperoxaluria Drug Sales by Type (2019-2024) & (K Pcs)
Table 8. Global Primary Hyperoxaluria Drug Sales Market Share by Type (2019-2024)
Table 9. Global Primary Hyperoxaluria Drug Revenue by Type (2019-2024) & ($ million)
Table 10. Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2019-2024)
Table 11. Global Primary Hyperoxaluria Drug Sale Price by Type (2019-2024) & (USD/Pcs)
Table 12. Global Primary Hyperoxaluria Drug Sales by Application (2019-2024) & (K Pcs)
Table 13. Global Primary Hyperoxaluria Drug Sales Market Share by Application (2019-2024)
Table 14. Global Primary Hyperoxaluria Drug Revenue by Application (2019-2024)
Table 15. Global Primary Hyperoxaluria Drug Revenue Market Share by Application (2019-2024)
Table 16. Global Primary Hyperoxaluria Drug Sale Price by Application (2019-2024) & (USD/Pcs)
Table 17. Global Primary Hyperoxaluria Drug Sales by Company (2019-2024) & (K Pcs)
Table 18. Global Primary Hyperoxaluria Drug Sales Market Share by Company (2019-2024)
Table 19. Global Primary Hyperoxaluria Drug Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Primary Hyperoxaluria Drug Revenue Market Share by Company (2019-2024)
Table 21. Global Primary Hyperoxaluria Drug Sale Price by Company (2019-2024) & (USD/Pcs)
Table 22. Key Manufacturers Primary Hyperoxaluria Drug Producing Area Distribution and Sales Area
Table 23. Players Primary Hyperoxaluria Drug Products Offered
Table 24. Primary Hyperoxaluria Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Primary Hyperoxaluria Drug Sales by Geographic Region (2019-2024) & (K Pcs)
Table 28. Global Primary Hyperoxaluria Drug Sales Market Share Geographic Region (2019-2024)
Table 29. Global Primary Hyperoxaluria Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Primary Hyperoxaluria Drug Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Primary Hyperoxaluria Drug Sales by Country/Region (2019-2024) & (K Pcs)
Table 32. Global Primary Hyperoxaluria Drug Sales Market Share by Country/Region (2019-2024)
Table 33. Global Primary Hyperoxaluria Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Primary Hyperoxaluria Drug Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Primary Hyperoxaluria Drug Sales by Country (2019-2024) & (K Pcs)
Table 36. Americas Primary Hyperoxaluria Drug Sales Market Share by Country (2019-2024)
Table 37. Americas Primary Hyperoxaluria Drug Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Primary Hyperoxaluria Drug Revenue Market Share by Country (2019-2024)
Table 39. Americas Primary Hyperoxaluria Drug Sales by Type (2019-2024) & (K Pcs)
Table 40. Americas Primary Hyperoxaluria Drug Sales by Application (2019-2024) & (K Pcs)
Table 41. APAC Primary Hyperoxaluria Drug Sales by Region (2019-2024) & (K Pcs)
Table 42. APAC Primary Hyperoxaluria Drug Sales Market Share by Region (2019-2024)
Table 43. APAC Primary Hyperoxaluria Drug Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Primary Hyperoxaluria Drug Revenue Market Share by Region (2019-2024)
Table 45. APAC Primary Hyperoxaluria Drug Sales by Type (2019-2024) & (K Pcs)
Table 46. APAC Primary Hyperoxaluria Drug Sales by Application (2019-2024) & (K Pcs)
Table 47. Europe Primary Hyperoxaluria Drug Sales by Country (2019-2024) & (K Pcs)
Table 48. Europe Primary Hyperoxaluria Drug Sales Market Share by Country (2019-2024)
Table 49. Europe Primary Hyperoxaluria Drug Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Primary Hyperoxaluria Drug Revenue Market Share by Country (2019-2024)
Table 51. Europe Primary Hyperoxaluria Drug Sales by Type (2019-2024) & (K Pcs)
Table 52. Europe Primary Hyperoxaluria Drug Sales by Application (2019-2024) & (K Pcs)
Table 53. Middle East & Africa Primary Hyperoxaluria Drug Sales by Country (2019-2024) & (K Pcs)
Table 54. Middle East & Africa Primary Hyperoxaluria Drug Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Primary Hyperoxaluria Drug Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Primary Hyperoxaluria Drug Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Primary Hyperoxaluria Drug Sales by Type (2019-2024) & (K Pcs)
Table 58. Middle East & Africa Primary Hyperoxaluria Drug Sales by Application (2019-2024) & (K Pcs)
Table 59. Key Market Drivers & Growth Opportunities of Primary Hyperoxaluria Drug
Table 60. Key Market Challenges & Risks of Primary Hyperoxaluria Drug
Table 61. Key Industry Trends of Primary Hyperoxaluria Drug
Table 62. Primary Hyperoxaluria Drug Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Primary Hyperoxaluria Drug Distributors List
Table 65. Primary Hyperoxaluria Drug Customer List
Table 66. Global Primary Hyperoxaluria Drug Sales Forecast by Region (2025-2030) & (K Pcs)
Table 67. Global Primary Hyperoxaluria Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Primary Hyperoxaluria Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 69. Americas Primary Hyperoxaluria Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Primary Hyperoxaluria Drug Sales Forecast by Region (2025-2030) & (K Pcs)
Table 71. APAC Primary Hyperoxaluria Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Primary Hyperoxaluria Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 73. Europe Primary Hyperoxaluria Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Primary Hyperoxaluria Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 75. Middle East & Africa Primary Hyperoxaluria Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Primary Hyperoxaluria Drug Sales Forecast by Type (2025-2030) & (K Pcs)
Table 77. Global Primary Hyperoxaluria Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Primary Hyperoxaluria Drug Sales Forecast by Application (2025-2030) & (K Pcs)
Table 79. Global Primary Hyperoxaluria Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Allena Pharmaceuticals Inc Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
Table 82. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Allena Pharmaceuticals Inc Main Business
Table 84. Allena Pharmaceuticals Inc Latest Developments
Table 85. Alnylam Pharmaceuticals Inc Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
Table 87. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Alnylam Pharmaceuticals Inc Main Business
Table 89. Alnylam Pharmaceuticals Inc Latest Developments
Table 90. Dicerna Pharmaceuticals Inc Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
Table 92. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. Dicerna Pharmaceuticals Inc Main Business
Table 94. Dicerna Pharmaceuticals Inc Latest Developments
Table 95. Intellia Therapeutics Inc Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product Portfolios and Specifications
Table 97. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Intellia Therapeutics Inc Main Business
Table 99. Intellia Therapeutics Inc Latest Developments
Table 100. OxThera AB Basic Information, Primary Hyperoxaluria Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. OxThera AB Primary Hyperoxaluria Drug Product Portfolios and Specifications
Table 102. OxThera AB Primary Hyperoxaluria Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. OxThera AB Main Business
Table 104. OxThera AB Latest Developments
LIST OF FIGURES
Figure 1. Picture of Primary Hyperoxaluria Drug
Figure 2. Primary Hyperoxaluria Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Primary Hyperoxaluria Drug Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Primary Hyperoxaluria Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Primary Hyperoxaluria Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of ALLN-230
Figure 10. Product Picture of DCR-PHXC
Figure 11. Product Picture of ALN-GO1
Figure 12. Product Picture of Others
Figure 13. Global Primary Hyperoxaluria Drug Sales Market Share by Type in 2023
Figure 14. Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2019-2024)
Figure 15. Primary Hyperoxaluria Drug Consumed in Hospital
Figure 16. Global Primary Hyperoxaluria Drug Market: Hospital (2019-2024) & (K Pcs)
Figure 17. Primary Hyperoxaluria Drug Consumed in Clinic
Figure 18. Global Primary Hyperoxaluria Drug Market: Clinic (2019-2024) & (K Pcs)
Figure 19. Primary Hyperoxaluria Drug Consumed in Others
Figure 20. Global Primary Hyperoxaluria Drug Market: Others (2019-2024) & (K Pcs)
Figure 21. Global Primary Hyperoxaluria Drug Sales Market Share by Application (2023)
Figure 22. Global Primary Hyperoxaluria Drug Revenue Market Share by Application in 2023
Figure 23. Primary Hyperoxaluria Drug Sales Market by Company in 2023 (K Pcs)
Figure 24. Global Primary Hyperoxaluria Drug Sales Market Share by Company in 2023
Figure 25. Primary Hyperoxaluria Drug Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Primary Hyperoxaluria Drug Revenue Market Share by Company in 2023
Figure 27. Global Primary Hyperoxaluria Drug Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Primary Hyperoxaluria Drug Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Primary Hyperoxaluria Drug Sales 2019-2024 (K Pcs)
Figure 30. Americas Primary Hyperoxaluria Drug Revenue 2019-2024 ($ Millions)
Figure 31. APAC Primary Hyperoxaluria Drug Sales 2019-2024 (K Pcs)
Figure 32. APAC Primary Hyperoxaluria Drug Revenue 2019-2024 ($ Millions)
Figure 33. Europe Primary Hyperoxaluria Drug Sales 2019-2024 (K Pcs)
Figure 34. Europe Primary Hyperoxaluria Drug Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Primary Hyperoxaluria Drug Sales 2019-2024 (K Pcs)
Figure 36. Middle East & Africa Primary Hyperoxaluria Drug Revenue 2019-2024 ($ Millions)
Figure 37. Americas Primary Hyperoxaluria Drug Sales Market Share by Country in 2023
Figure 38. Americas Primary Hyperoxaluria Drug Revenue Market Share by Country in 2023
Figure 39. Americas Primary Hyperoxaluria Drug Sales Market Share by Type (2019-2024)
Figure 40. Americas Primary Hyperoxaluria Drug Sales Market Share by Application (2019-2024)
Figure 41. United States Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Primary Hyperoxaluria Drug Sales Market Share by Region in 2023
Figure 46. APAC Primary Hyperoxaluria Drug Revenue Market Share by Regions in 2023
Figure 47. APAC Primary Hyperoxaluria Drug Sales Market Share by Type (2019-2024)
Figure 48. APAC Primary Hyperoxaluria Drug Sales Market Share by Application (2019-2024)
Figure 49. China Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Primary Hyperoxaluria Drug Sales Market Share by Country in 2023
Figure 57. Europe Primary Hyperoxaluria Drug Revenue Market Share by Country in 2023
Figure 58. Europe Primary Hyperoxaluria Drug Sales Market Share by Type (2019-2024)
Figure 59. Europe Primary Hyperoxaluria Drug Sales Market Share by Application (2019-2024)
Figure 60. Germany Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Primary Hyperoxaluria Drug Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Primary Hyperoxaluria Drug Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Primary Hyperoxaluria Drug Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Primary Hyperoxaluria Drug Sales Market Share by Application (2019-2024)
Figure 69. Egypt Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Primary Hyperoxaluria Drug in 2023
Figure 75. Manufacturing Process Analysis of Primary Hyperoxaluria Drug
Figure 76. Industry Chain Structure of Primary Hyperoxaluria Drug
Figure 77. Channels of Distribution
Figure 78. Global Primary Hyperoxaluria Drug Sales Market Forecast by Region (2025-2030)
Figure 79. Global Primary Hyperoxaluria Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Primary Hyperoxaluria Drug Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Primary Hyperoxaluria Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Primary Hyperoxaluria Drug Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Primary Hyperoxaluria Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Primary Hyperoxaluria Drug
Figure 2. Primary Hyperoxaluria Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Primary Hyperoxaluria Drug Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Primary Hyperoxaluria Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Primary Hyperoxaluria Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of ALLN-230
Figure 10. Product Picture of DCR-PHXC
Figure 11. Product Picture of ALN-GO1
Figure 12. Product Picture of Others
Figure 13. Global Primary Hyperoxaluria Drug Sales Market Share by Type in 2023
Figure 14. Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2019-2024)
Figure 15. Primary Hyperoxaluria Drug Consumed in Hospital
Figure 16. Global Primary Hyperoxaluria Drug Market: Hospital (2019-2024) & (K Pcs)
Figure 17. Primary Hyperoxaluria Drug Consumed in Clinic
Figure 18. Global Primary Hyperoxaluria Drug Market: Clinic (2019-2024) & (K Pcs)
Figure 19. Primary Hyperoxaluria Drug Consumed in Others
Figure 20. Global Primary Hyperoxaluria Drug Market: Others (2019-2024) & (K Pcs)
Figure 21. Global Primary Hyperoxaluria Drug Sales Market Share by Application (2023)
Figure 22. Global Primary Hyperoxaluria Drug Revenue Market Share by Application in 2023
Figure 23. Primary Hyperoxaluria Drug Sales Market by Company in 2023 (K Pcs)
Figure 24. Global Primary Hyperoxaluria Drug Sales Market Share by Company in 2023
Figure 25. Primary Hyperoxaluria Drug Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Primary Hyperoxaluria Drug Revenue Market Share by Company in 2023
Figure 27. Global Primary Hyperoxaluria Drug Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Primary Hyperoxaluria Drug Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Primary Hyperoxaluria Drug Sales 2019-2024 (K Pcs)
Figure 30. Americas Primary Hyperoxaluria Drug Revenue 2019-2024 ($ Millions)
Figure 31. APAC Primary Hyperoxaluria Drug Sales 2019-2024 (K Pcs)
Figure 32. APAC Primary Hyperoxaluria Drug Revenue 2019-2024 ($ Millions)
Figure 33. Europe Primary Hyperoxaluria Drug Sales 2019-2024 (K Pcs)
Figure 34. Europe Primary Hyperoxaluria Drug Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Primary Hyperoxaluria Drug Sales 2019-2024 (K Pcs)
Figure 36. Middle East & Africa Primary Hyperoxaluria Drug Revenue 2019-2024 ($ Millions)
Figure 37. Americas Primary Hyperoxaluria Drug Sales Market Share by Country in 2023
Figure 38. Americas Primary Hyperoxaluria Drug Revenue Market Share by Country in 2023
Figure 39. Americas Primary Hyperoxaluria Drug Sales Market Share by Type (2019-2024)
Figure 40. Americas Primary Hyperoxaluria Drug Sales Market Share by Application (2019-2024)
Figure 41. United States Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Primary Hyperoxaluria Drug Sales Market Share by Region in 2023
Figure 46. APAC Primary Hyperoxaluria Drug Revenue Market Share by Regions in 2023
Figure 47. APAC Primary Hyperoxaluria Drug Sales Market Share by Type (2019-2024)
Figure 48. APAC Primary Hyperoxaluria Drug Sales Market Share by Application (2019-2024)
Figure 49. China Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Primary Hyperoxaluria Drug Sales Market Share by Country in 2023
Figure 57. Europe Primary Hyperoxaluria Drug Revenue Market Share by Country in 2023
Figure 58. Europe Primary Hyperoxaluria Drug Sales Market Share by Type (2019-2024)
Figure 59. Europe Primary Hyperoxaluria Drug Sales Market Share by Application (2019-2024)
Figure 60. Germany Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Primary Hyperoxaluria Drug Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Primary Hyperoxaluria Drug Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Primary Hyperoxaluria Drug Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Primary Hyperoxaluria Drug Sales Market Share by Application (2019-2024)
Figure 69. Egypt Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Primary Hyperoxaluria Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Primary Hyperoxaluria Drug in 2023
Figure 75. Manufacturing Process Analysis of Primary Hyperoxaluria Drug
Figure 76. Industry Chain Structure of Primary Hyperoxaluria Drug
Figure 77. Channels of Distribution
Figure 78. Global Primary Hyperoxaluria Drug Sales Market Forecast by Region (2025-2030)
Figure 79. Global Primary Hyperoxaluria Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Primary Hyperoxaluria Drug Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Primary Hyperoxaluria Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Primary Hyperoxaluria Drug Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Primary Hyperoxaluria Drug Revenue Market Share Forecast by Application (2025-2030)
